Chemotherapy, Checkpoint Inhibitor, and Targeted Therapies Likely to Cause Diarrhea

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.1092" ]
    } ]
  },
  "date" : "2019-02-27T01:00:10-05:00",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "Oncology Nursing Society Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This value set contains concepts related to generic chemotherapies and other cancer treatment drugs which are likely to cause diarrhea in patients.),(Data Element Scope: This value set would use the Medication QDM category.),(Inclusion Criteria: This value set includes a variety of chemotherapies, checkpoint inhibitors and targeted therapies which may cause diarrhea.),(Exclusion Criteria: Brand name drugs and those not prescribable for humans have been excluded from this value set.)",
  "name" : "ChemotherapyCheckpointInhibitorAndTargetedTherapiesLikelyToCauseDiarrhea",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1098416",
      "display" : "vandetanib 100 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1098418",
      "display" : "vandetanib 300 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1119400",
      "display" : "everolimus 7.5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1147223",
      "display" : "vemurafenib 240 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1148498",
      "display" : "crizotinib 200 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1148504",
      "display" : "crizotinib 250 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1243004",
      "display" : "axitinib 1 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1243012",
      "display" : "axitinib 5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1298948",
      "display" : "14 ML pertuzumab 30 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1308428",
      "display" : "everolimus 2 MG Tablet for Oral Suspension",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1308430",
      "display" : "everolimus 3 MG Tablet for Oral Suspension",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1308432",
      "display" : "everolimus 5 MG Tablet for Oral Suspension",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1312402",
      "display" : "regorafenib 40 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1363273",
      "display" : "cabozantinib 20 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1363281",
      "display" : "cabozantinib 80 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1363312",
      "display" : "{84 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1363409",
      "display" : "{28 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1364580",
      "display" : "{84 (cabozantinib 20 MG Oral Capsule) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1424916",
      "display" : "dabrafenib 50 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1424918",
      "display" : "dabrafenib 75 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1425104",
      "display" : "trametinib 0.5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1425116",
      "display" : "trametinib 2 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1430446",
      "display" : "afatinib 20 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1430451",
      "display" : "afatinib 30 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1430455",
      "display" : "afatinib 40 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1541890",
      "display" : "sunitinib 37.5 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657005",
      "display" : "40 ML ipilimumab 5 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657012",
      "display" : "10 ML ipilimumab 5 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657066",
      "display" : "4 ML bevacizumab 25 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657073",
      "display" : "16 ML bevacizumab 25 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657658",
      "display" : "50 ML cetuximab 2 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657663",
      "display" : "100 ML cetuximab 2 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657703",
      "display" : "5 ML panitumumab 20 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657722",
      "display" : "20 ML panitumumab 20 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1723187",
      "display" : "8 ML ziv-aflibercept 25 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1723193",
      "display" : "4 ML ziv-aflibercept 25 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790161",
      "display" : "cabozantinib 20 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790169",
      "display" : "cabozantinib 40 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790173",
      "display" : "cabozantinib 60 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2046140",
      "display" : "16 ML bevacizumab-awwb 25 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2046148",
      "display" : "4 ML bevacizumab-awwb 25 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2056895",
      "display" : "everolimus 1 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "349472",
      "display" : "gefitinib 250 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "403878",
      "display" : "imatinib 100 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "403879",
      "display" : "imatinib 400 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "597747",
      "display" : "sorafenib 200 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "616279",
      "display" : "sunitinib 12.5 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "616285",
      "display" : "sunitinib 25 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "616289",
      "display" : "sunitinib 50 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "672149",
      "display" : "lapatinib 250 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "845507",
      "display" : "everolimus 10 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "845515",
      "display" : "everolimus 5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "867502",
      "display" : "pazopanib 200 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "867508",
      "display" : "pazopanib 400 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "977427",
      "display" : "everolimus 0.25 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "977434",
      "display" : "everolimus 0.5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "977438",
      "display" : "everolimus 0.75 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "998189",
      "display" : "everolimus 2.5 MG Oral Tablet",
      "version" : "05062024"
    } ],
    "total" : 58,
    "identifier" : "urn:uuid:82e2ee76-66a1-4c9b-b6f1-2d61bc304804",
    "timestamp" : "2024-06-14T18:10:59-04:00"
  },
  "title" : "Chemotherapy, Checkpoint Inhibitor, and Targeted Therapies Likely to Cause Diarrhea",
  "extension" : [ {
    "valueString" : "Oncology Nursing Society Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-06-03",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2019-02-27",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "retired",
  "id" : "2.16.840.1.113883.3.7643.3.1074",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.3.1074",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.7643.3.1074"
  } ],
  "version" : "20190227"
}